CTLT - Trade Savi - 360-degree view on crypto market

CTLT NVO

Novo Holdings completes $16.5 billion takeover of Catalent

Novo Holdings has acquired Catalent for $16.5 billion, enhancing production capabilities for the popular weight-loss drug Wegovy amid concerns from consumer groups and unions.

investing.com • 18/12/2024 - 14:08 PM

CTLT NVO

Novo Nordisk stock rises following regulatory clearance of Catalent deal

Novo Nordisk shares rose 2% after fulfilling regulatory conditions for its deal with Catalent, indicating a transition to private ownership and enhanced manufacturing capacity.

investing.com • 16/12/2024 - 16:23 PM

CTLT DANO NVO WMT

GLP-1: Barclays on why 2025 could be an inflection point

GLP-1 drugs may transform by 2025, driven by new therapies, increased production, and industry adaptations. Their role in weight loss and potential treatments for other conditions are vital.

investing.com • 16/12/2024 - 14:32 PM

CTLT NVO

Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say

Novo Holdings has fulfilled all closing conditions for its $16.5 billion acquisition of Catalent, enabling its completion soon, amid scrutiny and EU antitrust approval.

investing.com • 14/12/2024 - 16:53 PM

CTLT NVO

Novo Holdings' $16.5 billion Catalent buy wins EU antitrust approval

Novo Holdings received EU antitrust approval for its $16.5 billion acquisition of Catalent, with no competition issues reported, allowing closure by year-end.

investing.com • 06/12/2024 - 18:04 PM

CTLT LLY NVO

Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars

Eli Lilly announces a $3 billion investment to expand its Wisconsin plant, boosting production for weight-loss and diabetes drugs amid rising demand and previous shortages.

investing.com • 05/12/2024 - 20:43 PM

CTLT LLY NVO

EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 billion deal

EU regulators are reviewing Novo Holdings' $16.5 billion acquisition of Catalent, seeking feedback on market competition concerns and vertical links in contract manufacturing sectors.

investing.com • 13/11/2024 - 17:42 PM

CTLT LLY NVO

Catalent misses Q1 revenue estimates ahead of $16.5 billion deal close with Novo Holdings

Catalent reports a surprising first-quarter loss amid Novo Holdings acquisition plans, with revenue falling short of expectations, raising antitrust concerns over competition in the weight-loss drug market.

investing.com • 05/11/2024 - 13:25 PM

CTLT

Catalent reports Q1 loss, misses market expectations

Catalent's Q1 fiscal 2025 results revealed a loss per share of $0.13 and revenue of $1.02 billion, both missing analyst expectations despite some year-over-year growth.

investing.com • 05/11/2024 - 12:13 PM

C CTLT NVO

Citi hires top dealmaker Jeff Stute from Perella to bolster healthcare M&A ranks

Jeff Stute joins Citigroup as vice chair for healthcare mergers, aiming to enhance the bank's market share amid declining healthcare deal volumes.

investing.com • 04/11/2024 - 14:14 PM

Greed and Fear Index

Currency